Square Pharmaceuticals PLC.

SQURPHARMA

BD0473SQPH00

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
207.7 ^BDT	-2.07%		-2.99%	-1.24%

Feb. 01	Square Pharmaceuticals PLC. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Square Pharmaceuticals PLC. Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

Square Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2019; Approves BMRE, Capital Machineries and Lands Purchase

October 23, 2019 at 11:10 am EDT

The Board of Directors of Square Pharmaceuticals Limited has recommended 42% cash dividend for the year ended on June 30, 2019.

The Board has also approved BDT 2,000 million for BMRE, Capital Machineries and Lands for future expansion.

Latest news about Square Pharmaceuticals PLC.

Square Pharmaceuticals PLC. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 01	CI
Square Pharmaceuticals PLC. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
Square Pharmaceuticals PLC. Recommends Cash Dividend for the Year Ended June 30, 2023	23-10-23	CI
Square Pharmaceuticals PLC Announces Contract Manufacturing Agreement with M/S Aristopharma Ltd	23-08-03	CI
Square Pharmaceuticals Limited has Changed its Name to Square Pharmaceuticals PLC	23-06-22	CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-02	CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-01-29	CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-14	CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-04-27	CI
Square Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-02-01	CI
Square Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-15	CI
Square Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021	21-10-24	CI
Square Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-07	CI
Square Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-01-31	CI
Square Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2020	20-11-15	CI
Square Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020	20-06-08	CI
Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir-COO	20-05-05	RE
Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir - COO	20-05-05	RE
Square Pharmaceuticals Limited to Establish A Virtually Wholly Owned Subsidiary Company	20-02-18	CI
Square Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-01-29	CI
Square Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2019	19-10-29	CI
Square Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2019; Approves BMRE, Capital Machineries and Lands Purchase	19-10-23	CI
Square Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	19-04-30	CI
Square Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2018	19-01-31	CI
Square Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2018; Approves BDT 2 Billion for BMRE, Capital Machinery and Lands for Future Expansion	18-10-22	CI

Chart Square Pharmaceuticals PLC.

Duration

Period

More charts

Company Profile

Square Pharmaceuticals PLC. is a Bangladesh-based pharmaceutical company. The Company's products include pharma, herbal and nutraceutical, and agrovet and crop care. The Company's pharma products include Ace, Ace Plus, Ace Power, Aclitol Cozycap, Adryl, Acetram, Afun, Akicin, Alacot DS Eye Drops, Alacot Eye Drops, Alacot Max Eye Drops, Alarid Eye Drops, Alarid, Alice Lotion, Amodis 500 IV, Asynta Max, Avaspray, Axlovir Combipack, Ansulin Pen Cartridge, Angilock Plus, Clopirox Cream, Clopirox Shampoo, Contilex TS, Germisol Hand Rub, Glycovent Nebuliser Solution, Glysup, Gynepro and K-One MM. Its herbal and nutraceutical products include AmCivit, Antiscar, Arubin, Betaburn, Bioprem, Bolardi, Femony, Fitvit, Flemo Max, Flemo, Flemo Plus, Freezy, Lecor, Livolite, Maximilk, Monera, Redclov, Reli Balm, Revatol, Toco Soft, Torel, Trumega and ZanthinTM Softgel Capsule. Its agrovet and crop care products include Ace-Vet Bolus, Agrizeb 80 WP, Aqua Rock, Almex-Vet Bolus and Andopan Powder.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for Square Pharmaceuticals PLC.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

207.7 BDT

Average target price

321.8 BDT

Spread / Average Target

+54.91%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SQUARE PHARMACEUTICALS PLC.	-1.24%	1.68B
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals

Square Pharmaceuticals PLC.

Equities

SQURPHARMA

BD0473SQPH00

Pharmaceuticals

Square Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2019; Approves BMRE, Capital Machineries and Lands Purchase

Latest news about Square Pharmaceuticals PLC.

Chart Square Pharmaceuticals PLC.

Company Profile

Income Statement Evolution

Ratings for Square Pharmaceuticals PLC.

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals